Cargando…
Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?
Defining optimal adjuvant treatment for older women with breast cancer is challenged by the lack of level-1 clinical evidence and the heterogeneity of the older population. Nevertheless, recommendations based on reviews of available evidence mainly from retrospective subgroup analyses and extrapolat...
Autores principales: | Mislang, Anna Rachelle, Biganzoli, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586766/ https://www.ncbi.nlm.nih.gov/pubmed/26151681 http://dx.doi.org/10.3390/cancers7030833 |
Ejemplares similares
-
Optimization of Adjuvant Radiation in Breast Conservation Therapy: Can We Minimize without Compromise?
por: Edwards-Bennett, Sophia M., et al.
Publicado: (2011) -
Adjuvant systemic therapy in older women with breast cancer
por: Leone, Julieta, et al.
Publicado: (2016) -
A rare presentation of malignant mesothelioma of the tunica vaginalis managed with immunotherapy and review of the literature
por: Mishra, Kritika, et al.
Publicado: (2023) -
COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective
por: Loh, Kah Poh, et al.
Publicado: (2021) -
Optimizing Adjuvant Treatment Recommendations for Older Women with Biologically Favorable Breast Cancer: Short-Course Radiation or Long-Course Endocrine Therapy?
por: McDuff, Susan G. R., et al.
Publicado: (2022)